rabeprazole has been researched along with Alloxan Diabetes in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hossain, MJ | 1 |
| Sultan, MZ | 1 |
| Rashid, MA | 1 |
| Kuddus, MR | 1 |
1 other study available for rabeprazole and Alloxan Diabetes
| Article | Year |
|---|---|
Does Rabeprazole Sodium Alleviate the Anti-diabetic Activity of Linagliptin? Drug-Drug Interaction Analysis by In vitro and In vivo Methods.
Topics: Administration, Oral; Animals; Blood Glucose; Chromatography, High Pressure Liquid; Diabetes Mellitu | 2020 |